Skip to main content
. Author manuscript; available in PMC: 2022 Mar 19.
Published in final edited form as: Handb Clin Neurol. 2017;144:47–61. doi: 10.1016/B978-0-12-801893-4.00004-3

Table 3.

Advantages and disadvantages of different survival type methods for modeling age of motor-onset when genetic mutation status is known.

Method Advantages Disadvantages
Parametric methods (Gutierrez and MacDonald, 2002; Langbehn et al., 2004; Zhang et al., 2011) • Simple implementation.
• Predicts likeliness of onset occurring by a given age as an explicit function of subject-specific features.
• Predicts probability of onset in s-year intervals (e.g., 5-year intervals).
• Estimates penetrance rates at different CAG repeat-lengths.
• Provides clinically meaningful divisions of subjects to make crosssectional comparisons.
• Current parametric methods only incorporate CAG repeat-length and age-at-study entry, although many other subject-specific features have been identified to influence age-at-onset.
• Searching for explicit relationships between multiple subject-specific features and age-at-onset is challenging.
• Prone to model misspecification.
Semiparametric Cox model • Available in standard software.
• Relates linear effect of subject-specific features to a ratio of hazard functions through a log-transformation.
• Baseline hazard function left completely unspecified to allow model flexibility.
• Proportional hazards assumption not always satisfied in HD studies (Langbehn et al., 2004).
Nonparametric Kaplan-Meier • No assumptions about underlying age-at-onset distribution.
• Estimates age-at-onset distribution stratified by different subject-specific features (e.g., CAG repeat-length).
• No explicit relationship between the effect of CAG repeat-length and the age-at-onset distribution.
Nonparametric Kernel and Smoothing Splines (Ma and Wang, 2014b) • Effect of subject-specific features estimated using smooth functions that do not necessarily adhere to any particular explicit formula. • Computationally demanding.
• No explicit final model available and hence no clinically meaningful divisions of subjects.